These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

70 related items for PubMed ID: 21276137

  • 1. Resveratrol as an adjunct therapy in cyclophosphamide-treated MCF-7 cells and breast tumor explants.
    Singh N, Nigam M, Ranjan V, Zaidi D, Garg VK, Sharma S, Chaturvedi R, Shankar R, Kumar S, Sharma R, Mitra K, Balapure AK, Rath SK.
    Cancer Sci; 2011 May; 102(5):1059-67. PubMed ID: 21276137
    [Abstract] [Full Text] [Related]

  • 2. Caspase mediated enhanced apoptotic action of cyclophosphamide- and resveratrol-treated MCF-7 cells.
    Singh N, Nigam M, Ranjan V, Sharma R, Balapure AK, Rath SK.
    J Pharmacol Sci; 2009 Apr; 109(4):473-85. PubMed ID: 19372630
    [Abstract] [Full Text] [Related]

  • 3. Resveratrol down-regulates the growth and telomerase activity of breast cancer cells in vitro.
    Lanzilli G, Fuggetta MP, Tricarico M, Cottarelli A, Serafino A, Falchetti R, Ravagnan G, Turriziani M, Adamo R, Franzese O, Bonmassar E.
    Int J Oncol; 2006 Mar; 28(3):641-8. PubMed ID: 16465368
    [Abstract] [Full Text] [Related]

  • 4. Suppression of cell proliferation and gene expression by combinatorial synergy of EGCG, resveratrol and gamma-tocotrienol in estrogen receptor-positive MCF-7 breast cancer cells.
    Hsieh TC, Wu JM.
    Int J Oncol; 2008 Oct; 33(4):851-9. PubMed ID: 18813800
    [Abstract] [Full Text] [Related]

  • 5. Sensitization of human breast cancer cells to cyclophosphamide and ifosfamide by transfer of a liver cytochrome P450 gene.
    Chen L, Waxman DJ, Chen D, Kufe DW.
    Cancer Res; 1996 Mar 15; 56(6):1331-40. PubMed ID: 8640822
    [Abstract] [Full Text] [Related]

  • 6. Resveratrol chemosensitizes breast cancer cells to melphalan by cell cycle arrest.
    Casanova F, Quarti J, da Costa DC, Ramos CA, da Silva JL, Fialho E.
    J Cell Biochem; 2012 Aug 15; 113(8):2586-96. PubMed ID: 22415970
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Centchroman mediated apoptosis involves cross-talk between extrinsic/intrinsic pathways and oxidative regulation.
    Nigam M, Singh N, Ranjan V, Zaidi D, Sharma R, Nigam D, Gupta DK, Sundaram S, Balapure AK.
    Life Sci; 2010 Dec 18; 87(23-26):750-8. PubMed ID: 21034746
    [Abstract] [Full Text] [Related]

  • 9. Survivin plays as a resistant factor against tamoxifen-induced apoptosis in human breast cancer cells.
    Moriai R, Tsuji N, Moriai M, Kobayashi D, Watanabe N.
    Breast Cancer Res Treat; 2009 Sep 18; 117(2):261-71. PubMed ID: 18815881
    [Abstract] [Full Text] [Related]

  • 10. Effects of diverse dietary phytoestrogens on cell growth, cell cycle and apoptosis in estrogen-receptor-positive breast cancer cells.
    Sakamoto T, Horiguchi H, Oguma E, Kayama F.
    J Nutr Biochem; 2010 Sep 18; 21(9):856-64. PubMed ID: 19800779
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cyclophosphamide augments the anti-tumor efficacy of uracil and tegafur by inhibiting dihydropyrimidine dehydrogenase.
    Nio Y, Iguchi C, Kodama H, Itakura M, Hashimoto K, Koike M, Toga T, Maruyama R, Fukushima M.
    Oncol Rep; 2007 Jan 18; 17(1):153-9. PubMed ID: 17143493
    [Abstract] [Full Text] [Related]

  • 14. A novel resveratrol-salinomycin combination sensitizes ER-positive breast cancer cells to apoptosis.
    Venkatadri R, Iyer AKV, Kaushik V, Azad N.
    Pharmacol Rep; 2017 Aug 18; 69(4):788-797. PubMed ID: 28605700
    [Abstract] [Full Text] [Related]

  • 15. Anti-breast cancer effects of histone deacetylase inhibitors and calpain inhibitor.
    Mataga MA, Rosenthal S, Heerboth S, Devalapalli A, Kokolus S, Evans LR, Longacre M, Housman G, Sarkar S.
    Anticancer Res; 2012 Jul 18; 32(7):2523-9. PubMed ID: 22753709
    [Abstract] [Full Text] [Related]

  • 16. Trastuzumab enhances the anti-tumor effects of the histone deacetylase inhibitor sodium butyrate on a HER2-overexpressing breast cancer cell line.
    Chen W, Wei F, Xu J, Wang Y, Chen L, Wang J, Guan X.
    Int J Mol Med; 2011 Dec 18; 28(6):985-91. PubMed ID: 21887460
    [Abstract] [Full Text] [Related]

  • 17. Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer.
    Liu H, Zang C, Emde A, Planas-Silva MD, Rosche M, Kühnl A, Schulz CO, Elstner E, Possinger K, Eucker J.
    Eur J Pharmacol; 2008 Sep 04; 591(1-3):43-51. PubMed ID: 18588872
    [Abstract] [Full Text] [Related]

  • 18. Differential expression of genes induced by resveratrol in human breast cancer cell lines.
    Le Corre L, Chalabi N, Delort L, Bignon YJ, Bernard-Gallon DJ.
    Nutr Cancer; 2006 Sep 04; 56(2):193-203. PubMed ID: 17474865
    [Abstract] [Full Text] [Related]

  • 19. [Three cases of metastatic breast cancer, resistant to pre-chemo and/or endocrine therapy, markedly improved with UFT and cyclophosphamide oral combination therapy].
    Ogawa Y, Ishikawa T, Ogisawa K, Ikeda K, Nagatsuka I, Matsumura Y, Takashima T, Yashiro M, Onoda N, Nakata B, Kato Y, Hirakawa K.
    Gan To Kagaku Ryoho; 2000 Nov 04; 27(13):2123-7. PubMed ID: 11103246
    [Abstract] [Full Text] [Related]

  • 20. Co-targeting the insulin-like growth factor I receptor enhances growth-inhibitory and pro-apoptotic effects of anti-estrogens in human breast cancer cell lines.
    Chakraborty AK, Welsh A, Digiovanna MP.
    Breast Cancer Res Treat; 2010 Apr 04; 120(2):327-35. PubMed ID: 19337828
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.